Stock Comparison
REGN vs RPRX
Regeneron Pharmaceuticals Inc and Royalty Pharma Plc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$80.55B
$33.14B
P/E (TTM)
19.4
30.8
Forward P/E
17.1
47.4
Price/Sales
5.2
13.1
Price/Book
2.5
3.7
EV/EBITDA
13.1
33.5
Dividend Yield
0.45%
1.55%
Profitability
Net Margin
29.65%
32.15%
Operating Margin
24.32%
62.34%
Return on Equity
14.00%
14.00%
Return on Assets
6.53%
5.09%
Growth (YoY)
Revenue Growth
16.70%
16.50%
Earnings Growth
-4.50%
-46.30%
Price & Risk
Beta
0.2
0.4
52-Week High
$810.12
$59.97
52-Week Low
$553.38
$34.37
Analyst Target
$833.54
$63.75
Compare REGN and RPRX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.